HCLTech shares will be watched after the company announced a strategic collaboration with AWS to accelerate digital transformation in the financial services sector. The partnership aims to modernise legacy systems, enhance customer experiences, and deploy AI-driven, industry-compliant solutions across banking, wealth, and insurance, strengthening long-standing ties between both companies.Read More
Zydus Lifesciences will be in focus on Wednesday after receiving final USFDA approval for its Verapamil Hydrochloride Extended-Release Tablets in 120 mg, 180 mg, and 240 mg strengths. The drug, a generic version of Calan SR, is used to treat high blood pressure. The approval strengthens Zydus’ US portfolio and supports its ongoing expansion in the regulated markets.Read More
Investors will know their Sudeep Pharma IPO allotment status on Wednesday. The offering saw strong demand. Grey market activity suggests a listing premium. Shares may list higher than the issue price. Refunds and demat credits are scheduled for November 27. The company is set to list on November 28 on NSE and BSE. A positive debut is expected.Read More
Gallard Steel is set for its market debut with a strong grey market premium of 38%, indicating a potential listing price of Rs 205-210. The engineered castings manufacturer saw an overwhelming subscription of 375.54 times for its Rs 37.5 crore SME IPO, driven by significant demand from non-institutional and retail investors.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
